{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.3616.200.110.102.6154","meta":{"versionId":"5","lastUpdated":"2020-08-18T10:21:27.000-04:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.6154","version":"20200710","name":"COVID19 SNOMED Value Set for Immunosuppressive Therapy Administration","status":"active","date":"2020-07-10T01:00:43-04:00","publisher":"Clinical Architecture","compose":{"include":[{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20220301","concept":[{"code":"707311008","display":"Immunosuppressant drug therapy (procedure)"},{"code":"713517003","display":"Infliximab therapy (procedure)"},{"code":"713518008","display":"Mycophenolate therapy (procedure)"},{"code":"713551004","display":"Azathioprine therapy (procedure)"},{"code":"722189006","display":"Abatacept therapy (procedure)"},{"code":"723945004","display":"Cyclosporine therapy (procedure)"},{"code":"724159000","display":"Rituximab therapy (procedure)"},{"code":"724160005","display":"Tacrolimus therapy (procedure)"},{"code":"724165000","display":"Tofacitinib therapy (procedure)"},{"code":"726599006","display":"Sirolimus therapy (procedure)"},{"code":"726603006","display":"Apremilast therapy (procedure)"},{"code":"7447008","display":"Immunosuppressive therapy for transplant (procedure)"},{"code":"782708002","display":"Everolimus therapy (procedure)"},{"code":"782710000","display":"Natalizumab therapy (procedure)"},{"code":"782711001","display":"Secukinumab therapy (procedure)"},{"code":"782712008","display":"Vedolizumab therapy (procedure)"},{"code":"86553008","display":"Immunosuppressive therapy (procedure)"}]}]}}